Rezolute stock crashes after sole pipeline candidate fails Phase III
Rezolute still has another Phase III trial of ersodetug in progress to rely upon, with data expected in H2 2026.
FDA grants clearance to Prilenia and Ferrer’s Phase III ALS therapy trial
APAC’s rising stars beyond China
AI takes charge of data, but challenges linger
Lindus Health and Quotient Sciences to support sponsors with trial recruitment
ASH 2025: J&J’s Tecvayli + Darzale set to redefine early relapse MM
Analysis
View More
Themes
View MorePatient-centric approaches thrive on wearables and remote access in trials
Experts discuss the use of artificial intelligence (AI) and patient-centric strategies in oncology clinical trials.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View more
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Pharma’s AI prospects get nudged into the future with EU’s AI act
Are regulators keeping pace with AI adoption in clinical trials?
AI-automated IVF procedures represent a new era in fertility treatment
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal